-
Je něco špatně v tomto záznamu ?
Impact of the complex humanitarian crisis on the epidemiology of the cardiometabolic risk factors in Venezuela
JP. González-Rivas, JI. Mechanick, C. Ponte, D. de Oliveira-Gomes, R. Iglesias-Fortes, L. Machado, M. Duran, MI. Marulanda, R. Nieto-Martínez
Jazyk xxx, angličtina Země Španělsko
Typ dokumentu časopisecké články, přehledy
- MeSH
- cholesterol MeSH
- dospělí MeSH
- hyperlipidemie * MeSH
- kardiometabolické riziko MeSH
- lidé MeSH
- metabolický syndrom * epidemiologie MeSH
- prevalence MeSH
- rizikové faktory MeSH
- Check Tag
- dospělí MeSH
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- přehledy MeSH
- Geografické názvy
- Venezuela MeSH
BACKGROUND: The complex humanitarian crisis (CHC) in Venezuela is characterized by food insecurity, hyperinflation, insufficient basic services, and the collapse of the healthcare system. The evolution of the epidemiology of cardiometabolic risk factors in this context is unknown. AIM: To compile the last 20 years evidence on the prevalence of cardiometabolic risk factors in adults of Venezuela in the context of the CHC. METHODS: A comprehensive literature review of population-based studies of adults in Venezuela from 2000 to 2020. RESULTS: Seven studies (National EVESCAM 2014-2017, 3 regions VEMSOLS 2006-2010, Maracaibo city 2007-2010, Merida city 2015, Mucuchies city 2009, Barquisimeto city CARMELA 2003-2005, and Zulia state 1999-2001) with samples sizes ranging from 109 to 3414 subjects were included. Over time, apparent decrease was observed in smoking from 21.8% (2003-2005) to 11.7% (2014-2017) and for obesity from 33.3% (2007-2010) to 24.6% (2014-2017). In contrast, there was an apparent increase in diabetes from 6% (2003-2005) to 12.3% (2014-2017), prediabetes 14.6% (2006-2010) to 34.9% (2014-2017), and hypertension 24.7% (2003-2005) to 34.1% (2014-2017). The most prevalent dyslipidemia - a low HDL-cholesterol - remained between 65.3% (1999-2001) and 63.2% (2014-2017). From 2006-2010 to 2014-2017, the high total cholesterol (22.2% vs 19.8%, respectively) and high LDL-cholesterol (23.3% vs 20.5%, respectively) remained similar, but high triglycerides decreased (39.7% vs 22.7%, respectively). Using the same definition across all the studies, metabolic syndrome prevalence increased from 35.6% (2006-2010) to 47.6% (2014-2017). Insufficient physical activity remained steady from 2007-2010 (34.3%) to 2014-2017 (35.2%). CONCLUSION: Changes in the prevalence of cardiometabolic risk factors in Venezuela are heterogeneous and can be affected by various social determinants of health. Though the Venezuelan healthcare system has not successfully adapted, the dynamics and repercussions of the CHC on population-based cardiometabolic care can be instructive for other at-risk populations.
Cardiometabolic Medicine Unit La Floresta Clinical Institute Caracas Venezuela
Foundation for Clinic Public Health and Epidemiology Research of Venezuela Caracas Venezuela
International Clinical Research Center St Ann's University Hospital Brno Czech Republic
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22019257
- 003
- CZ-PrNML
- 005
- 20220804135457.0
- 007
- ta
- 008
- 220720s2022 sp f 000 0|eng s
- 009
- AR
- 024 7_
- $a 10.1016/j.arteri.2021.04.002 $2 doi
- 035 __
- $a (PubMed)34315627
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng spa
- 044 __
- $a sp
- 100 1_
- $a González-Rivas, Juan P $u International Clinical Research Center (ICRC), St. Ann's University Hospital, Brno, Czech Republic; Department of Global Health and Population, Harvard TH Chan School of Public Health, Harvard University, Boston, MA, USA; Foundation for Clinic, Public Health, and Epidemiology Research of Venezuela (FISPEVEN INC), Caracas, Venezuela. Electronic address: juan.gonzalez@fnusa.cz
- 245 10
- $a Impact of the complex humanitarian crisis on the epidemiology of the cardiometabolic risk factors in Venezuela / $c JP. González-Rivas, JI. Mechanick, C. Ponte, D. de Oliveira-Gomes, R. Iglesias-Fortes, L. Machado, M. Duran, MI. Marulanda, R. Nieto-Martínez
- 520 9_
- $a BACKGROUND: The complex humanitarian crisis (CHC) in Venezuela is characterized by food insecurity, hyperinflation, insufficient basic services, and the collapse of the healthcare system. The evolution of the epidemiology of cardiometabolic risk factors in this context is unknown. AIM: To compile the last 20 years evidence on the prevalence of cardiometabolic risk factors in adults of Venezuela in the context of the CHC. METHODS: A comprehensive literature review of population-based studies of adults in Venezuela from 2000 to 2020. RESULTS: Seven studies (National EVESCAM 2014-2017, 3 regions VEMSOLS 2006-2010, Maracaibo city 2007-2010, Merida city 2015, Mucuchies city 2009, Barquisimeto city CARMELA 2003-2005, and Zulia state 1999-2001) with samples sizes ranging from 109 to 3414 subjects were included. Over time, apparent decrease was observed in smoking from 21.8% (2003-2005) to 11.7% (2014-2017) and for obesity from 33.3% (2007-2010) to 24.6% (2014-2017). In contrast, there was an apparent increase in diabetes from 6% (2003-2005) to 12.3% (2014-2017), prediabetes 14.6% (2006-2010) to 34.9% (2014-2017), and hypertension 24.7% (2003-2005) to 34.1% (2014-2017). The most prevalent dyslipidemia - a low HDL-cholesterol - remained between 65.3% (1999-2001) and 63.2% (2014-2017). From 2006-2010 to 2014-2017, the high total cholesterol (22.2% vs 19.8%, respectively) and high LDL-cholesterol (23.3% vs 20.5%, respectively) remained similar, but high triglycerides decreased (39.7% vs 22.7%, respectively). Using the same definition across all the studies, metabolic syndrome prevalence increased from 35.6% (2006-2010) to 47.6% (2014-2017). Insufficient physical activity remained steady from 2007-2010 (34.3%) to 2014-2017 (35.2%). CONCLUSION: Changes in the prevalence of cardiometabolic risk factors in Venezuela are heterogeneous and can be affected by various social determinants of health. Though the Venezuelan healthcare system has not successfully adapted, the dynamics and repercussions of the CHC on population-based cardiometabolic care can be instructive for other at-risk populations.
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a kardiometabolické riziko $7 D000083202
- 650 _2
- $a cholesterol $7 D002784
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a hyperlipidemie $7 D006949
- 650 12
- $a metabolický syndrom $x epidemiologie $7 D024821
- 650 _2
- $a prevalence $7 D015995
- 650 _2
- $a rizikové faktory $7 D012307
- 651 _2
- $a Venezuela $x epidemiologie $7 D014687
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Mechanick, Jeffrey I $u The Marie-Josée and Henry R. Kravis Center for Cardiovascular Health at Mount Sinai Heart, Division of Endocrinology, Diabetes and Bone Disease, Icahn School of Medicine at Mount Sinai, New York, NY, USA
- 700 1_
- $a Ponte, Carlos $u Cardiometabolic Medicine Unit La Floresta Clinical Institute, Caracas, Venezuela
- 700 1_
- $a de Oliveira-Gomes, Diana $u Foundation for Clinic, Public Health, and Epidemiology Research of Venezuela (FISPEVEN INC), Caracas, Venezuela
- 700 1_
- $a Iglesias-Fortes, Rocio $u Foundation for Clinic, Public Health, and Epidemiology Research of Venezuela (FISPEVEN INC), Caracas, Venezuela
- 700 1_
- $a Machado, Livia $u Nutrition Unit, Santa Sofia Clinic, Caracas, Venezuela
- 700 1_
- $a Duran, Maritza $u Foundation for Clinic, Public Health, and Epidemiology Research of Venezuela (FISPEVEN INC), Caracas, Venezuela
- 700 1_
- $a Marulanda, Maria Inés $u Foundation for Clinic, Public Health, and Epidemiology Research of Venezuela (FISPEVEN INC), Caracas, Venezuela
- 700 1_
- $a Nieto-Martínez, Ramfis $u Department of Global Health and Population, Harvard TH Chan School of Public Health, Harvard University, Boston, MA, USA; Foundation for Clinic, Public Health, and Epidemiology Research of Venezuela (FISPEVEN INC), Caracas, Venezuela; LifeDoc Health, Memphis, TN, USA
- 773 0_
- $w MED00209419 $t Clinica e investigacion en arteriosclerosis : publicacion oficial de la Sociedad Espanola de Arteriosclerosis $x 1578-1879 $g Roč. 34, č. 2 (2022), s. 97-104
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/34315627 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20220720 $b ABA008
- 991 __
- $a 20220804135451 $b ABA008
- 999 __
- $a ok $b bmc $g 1822731 $s 1170500
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2022 $b 34 $c 2 $d 97-104 $e 20210724 $i 1578-1879 $m Clínica e investigación en arteriosclerosis $n Clin Investig Arterioscler $x MED00209419
- LZP __
- $a Pubmed-20220720